A couple weeks ago I had the pleasure of sitting down for an interview with Rhonda Schaffler at Reuters Insider in New York. We covered a little bit of everything, including my hedge fund days and the transition from short selling to what I have been most focused on as of late, Okyanos Heart Institute.
In the interview itself we talked a little about Okyanos and our mission, which is to provide a new standard of care for heart disease patients through cardiac cell therapy. Okyanos treatment involves isolating adult stem cells from the patient’s own body fat, which are then reintroduced into the heart muscle. In other words, capitalizing on the body’s own natural biology and enabling the heart to, in a way, heal itself.
I am very grateful for the opportunity to speak about our purpose at Okyanos. We have assembled a great team and a very supportive, like-minded group of investors, and I look forward to being able to treat patients at our center in The Bahamas in the coming months. Many thanks to Rhonda and the Reuters team for having me on – it was a pleasure.
View the complete interview here.
Tags: interview, Okyanos Heart Institute, Reuters
Excellent, Matt! Tad